Gupta has been serving as the GCOO of the Company since February 2025, overseeing Commercial markets, API, manufacturing and supply chain
Cipla has elevated Achin Gupta, Global Chief Operating Officer to MD and GCEO effective April 1, 2026, for a term of five years. The appointment will be proposed to the shareholders for their approval. Achin has been appointed as MD and GCEO Designate from January 1st, 2026. Achin will succeed Umang Vohra who has served as the MD and GCEO of Cipla since 2016.
Gupta has been serving as the GCOO of the Company since February 2025, overseeing Commercial markets, API, manufacturing and supply chain. He joined Cipla in 2021 as the CEO of the One India business and has been an integral member of the Management Council. He has driven strong growth, expanded Cipla’s reach in chronic therapies and underserved geographies, and strengthened its core operations. Under his leadership, the India business delivered market-leading profitability, modernized its retail force, and introduced consumer-focused innovations.
Gupta also forged strategic global partnerships, positioning Cipla as a preferred innovation-led
collaborator. Achin holds a M Tech degree from IIT Delhi, specialising in Biochemical Engineering
and Biotechnology and an MBA from IIM, Ahmedabad.
In over two decades of his career, Gupta has built a strong track record as an entrepreneurial
leader. Achin is known for building new frontiers and fostering a culture of purpose, innovation,
and accountability.
Vohra who joined Cipla in 2015 as Global Chief Financial & Strategy Officer and thereafter
served as Cipla’s MD and GCEO since 2016. Over the past decade, Umang has led Cipla through a
period of effective transformation, guided by the company’s purpose of Caring for Life. His
leadership has been instrumental in driving strategic growth, financial performance, innovation,
and operational excellence across the organisation.
Dr YK Hamied, Chairman, Cipla Limited said, “I thank Vohra for his stewardship over the last ten years, his outstanding contributions and dedication to Cipla’s purpose of Caring for Life and combining business with a humanitarian approach. We wish Umang continued success in his future career. We are pleased to welcome Gupta as he steps into this role, and I am confident he will lead Cipla to its next phase of progress and growth.
Vohra said, “My ten years at Cipla has been filled with immense pride in what we’ve built together. Guided by our purpose of Caring for Life, I have had the privilege of working with passionate teams who consistently put patients first and drive innovation across the business.
Gupta stated, “It is an honour to be entrusted with the responsibility of leading Cipla as its next MD & GCEO. Cipla’s legacy of purpose-driven innovation and patient-centric care is deeply inspiring, and I am committed to building on the strong foundation laid by Umang and the leadership team. Over the past few years, I’ve had the privilege of working closely with teams across the organisation and witnessing
firsthand the passion, resilience, and commitment that define Cipla. As we move forward, my focus will remain on driving sustainable growth, deepening our impact across markets, and continuing to innovate with purpose."
